Yidu Tech Secures SGD 2.28 Million Dr Buddy Contract with Singapore Health Services

Bulletin Express

05/06

Yidu Tech Inc. (Yidu Tech) announced that its subsidiary, EVYD Research Private Limited, has won the tender from Singapore Health Services Pte Ltd to implement, support and maintain the “Dr Buddy” platform. The contract value is approximately SGD 2.28 million, marking a strategic milestone in the company’s expansion into the Singapore healthcare market.

The project will deploy Yidu Tech’s disease-focused artificial intelligence, designed to replicate physicians’ clinical decision-making and enhance precision medicine delivery. Management highlighted the initiative as a key step toward extending the company’s intelligent healthcare solutions beyond China, reinforcing its mission to empower healthcare providers, pharmaceutical partners, payers and patients through data-driven decision tools.

The voluntary announcement was released in Hong Kong on 6 May 2026 and was signed by Executive Director and Chairlady Gong Yingying on behalf of the Board.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1109287778"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1109287778\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1109287778?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-06 06:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1109287778","market":"hk","top_or_hot":-1,"title":"Yidu Tech Secures SGD 2.28 Million Dr Buddy Contract with Singapore Health Services","media":"Bulletin Express","content":"<p>Yidu Tech Inc. (Yidu Tech) announced that its subsidiary, EVYD Research Private Limited, has won the tender from Singapore Health Services Pte Ltd to implement, support and maintain the “Dr Buddy” platform. The contract value is approximately SGD 2.28 million, marking a strategic milestone in the company’s expansion into the Singapore healthcare market.</p>\n<p>The project will deploy Yidu Tech’s disease-focused artificial intelligence, designed to replicate physicians’ clinical decision-making and enhance precision medicine delivery. Management highlighted the initiative as a key step toward extending the company’s intelligent healthcare solutions beyond China, reinforcing its mission to empower healthcare providers, pharmaceutical partners, payers and patients through data-driven decision tools.</p>\n<p>The voluntary announcement was released in Hong Kong on 6 May 2026 and was signed by Executive Director and Chairlady Gong Yingying on behalf of the Board.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Yidu Tech Secures SGD 2.28 Million Dr Buddy Contract with Singapore Health Services</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYidu Tech Secures SGD 2.28 Million Dr Buddy Contract with Singapore Health Services\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-05-06 06:22</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Yidu Tech Inc. (Yidu Tech) announced that its subsidiary, EVYD Research Private Limited, has won the tender from Singapore Health Services Pte Ltd to implement, support and maintain the “Dr Buddy” platform. The contract value is approximately SGD 2.28 million, marking a strategic milestone in the company’s expansion into the Singapore healthcare market.</p>\n<p>The project will deploy Yidu Tech’s disease-focused artificial intelligence, designed to replicate physicians’ clinical decision-making and enhance precision medicine delivery. Management highlighted the initiative as a key step toward extending the company’s intelligent healthcare solutions beyond China, reinforcing its mission to empower healthcare providers, pharmaceutical partners, payers and patients through data-driven decision tools.</p>\n<p>The voluntary announcement was released in Hong Kong on 6 May 2026 and was signed by Executive Director and Chairlady Gong Yingying on behalf of the Board.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02158","symbol_name":"醫渡科技","start_time":0,"source_url":"","article_id":"1109287778","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1109287778","pubTimestamp":1778019771,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Yidu Tech Inc. (Yidu Tech) announced that its subsidiary, EVYD Research Private Limited, has won the tender from Singapore Health Services Pte Ltd to implement, support and maintain the 「Dr Buddy」...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02158":"医渡科技"},"translate_title":"医渡科技与新加坡医疗服务机构签订价值228万新元的Dr Buddy合同","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02158":1},"content_text":"Yidu Tech Inc. (Yidu Tech) announced that its subsidiary, EVYD Research Private Limited, has won the tender from Singapore Health Services Pte Ltd to implement, support and maintain the 「Dr Buddy」 platform. The contract value is approximately SGD 2.28 million, marking a strategic milestone in the company’s expansion into the Singapore healthcare market.\nThe project will deploy Yidu Tech’s disease-focused artificial intelligence, designed to replicate physicians’ clinical decision-making and enhance precision medicine delivery. Management highlighted the initiative as a key step toward extending the company’s intelligent healthcare solutions beyond China, reinforcing its mission to empower healthcare providers, pharmaceutical partners, payers and patients through data-driven decision tools.\nThe voluntary announcement was released in Hong Kong on 6 May 2026 and was signed by Executive Director and Chairlady Gong Yingying on behalf of the Board.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}